Oryzon Genomics
Latest round
- Series B
Last raised
- Mar 2008
Total raised
- $17M
Investors
- 2
About Oryzon Genomics
A. operates as a biopharmaceutical company providing clinical-stage biopharmaceuticals that develops novel epigenetic therapies to treat oncology and neurodegenerative diseases.A. developed epigenetics-based therapeutics and medicines for treating cancer and neurodegenerative diseases. The company’s product has two drugs in Phase II clinical development such as iadademstat (also known as ORY-1001), a selective LSD1 inhibitor for oncology, and vafidemstat (also known as ORY-2001), a CNS optimized LSD1 inhibitor for CNS and psychiatric disorders. Its pipeline also includes another LSD1 inhibitor, ORY-3001, for the treatment of non-oncological diseases, ORY-4001, a selective HDAC6 inhibitor, and additional programs at earlier stages of development.
Who invested in Oryzon Genomics
2 investors across 1 round
See all investors in Oryzon Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 6, 2008
Amount
$17M
Investors
Questions about Oryzon Genomics
Who invested in Oryzon Genomics?
Oryzon Genomics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oryzon Genomics raised?
Oryzon Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oryzon Genomics last raise money?
Oryzon Genomics's most recent round on record is a Series B, in Mar 2008.
What does Oryzon Genomics do?
Oryzon Genomics is a biotechnology company.
Where is Oryzon Genomics headquartered?
Oryzon Genomics is headquartered in Madrid, Spain.
Which VCs invest in companies like Oryzon Genomics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Oryzon Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Oryzon Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.